Posts by: admin

Lung Cancer, News

A study led by Lindsey A. Torre from the American Cancer Society Intramural Research in Atlanta concluded that lung cancer mortality rates are higher in women aged 50 years and older ... Read more

May 29, 2014May 29, 2014

Researchers Develop 3D Artificial Lung To Develop Cancer Treatment

Lung Cancer, News

A group of researchers from the Regenerative Technologies For Oncology project (Fraunhofer Institute of Interfacial Engineering and Biotechnology IGB), along with the Department of Bioninformatics at the University of Würzburg, ... Read more

May 27, 2014November 6, 2015

New Phase 3 Trial Tests Therapy For Non-Cystic Fibrosis Bronchiectasis Exacerbations On Patients In China

Bronchiectasis, News

Jinmimg Gao, a Professor of Oncology and Pharmacology in the Department of Pharmacology, Simmons Comprehensive Cancer Center at UT Southwestern Medical Center, is the principal investigator of a Phase-3 clinical ... Read more

May 27, 2014November 6, 2015

FDA Grants Orphan Status To Edmond Pharma’s Bronchiectasis Drug

Bronchiectasis, News

The Food and Drug Administration (FDA) has granted Italian pharmaceutical company Edmond Pharma with the Orphan Drug Designation for their mucoactive drug Erdosteine, a therapy used for the treatment of bronchiectasis. According ... Read more

May 26, 2014November 11, 2015

Forest Laboratories, Inc. Presents Data of COPD Therapy Aclidinium, Aclidinium/Formoterol Combination, and Roflumilast

COPD, News

Forest Laboratories, Inc., a New York-based pharmaceutical company, announced that it will present data on TUDORZA PRESSAIR (aclidinium bromide inhalation powder), a combination use of aclidinium bromide/formoterol fumarate, and DALIRESP ... Read more

May 23, 2014November 11, 2015

COPD Patients Taking Benzodiazepines At Higher Risk For Exacerbation Events

COPD

New research has found that a group of drugs usually prescribed to treat insomnia, anxiety, and breathing issues has been related to a significant increase in the risk of COPD ... Read more

May 23, 2014November 11, 2015

Study Evaluates Rosuvastatin Therapy In COPD Patients

COPD, News

RODEO, a new study presented at the 2014 American Thoracic Society International Conference by Anky Neukamm, MD, of Akershus University Hospital in Norway, studied the effects on forced expiratory volume in ... Read more

May 20, 2014November 11, 2015

Anoro COPD Treatment Gets Marketing Authorization in Europe

COPD, News

The European Commission has granted marketing authorization for Anoro (Umeclidinium/Vilanterol), a chronic obstructive pulmonary disease (COPD) treatment, which is currently licensed in Europe as UMEC/VI55mcg/22mcg. GlaxoSmithKline and Theravance announced the now-authorized combination ... Read more